Report Detail

Request for Sample of this report

Agriculture Global Cyazofamid Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3144913
    • |
  • 19 March, 2019
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Agriculture

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Scope of the Report:
4-methylacetophenone is the main raw materials. Cyazofamid are often applied to treat downy mildew oomycetes diseases.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, which production reached 335 MT in 2016, with the share of 81.91%.
The consumption shares of Japan, China, North America and Europe were 42.79%, 21.52%, 17.11% and 11.74%. Japan is the main import region and other countries need to import from Japan.
The worldwide market for Cyazofamid is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 90 million US$ in 2024, from 82 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Cyazofamid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
ISHIHARA SANGYO KAISHA
Rudong Zhongyi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Type I
Type II

Market Segment by Applications, can be divided into
Downy Mildew
Oomycetes Diseases
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyazofamid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cyazofamid, with price, sales, revenue and global market share of Cyazofamid in 2017 and 2018.
Chapter 3, the Cyazofamid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyazofamid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cyazofamid market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cyazofamid sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Cyazofamid Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Type I
      • 1.2.2 Type II
    • 1.3 Market Analysis by Applications
      • 1.3.1 Downy Mildew
      • 1.3.2 Oomycetes Diseases
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 ISHIHARA SANGYO KAISHA
      • 2.1.1 Business Overview
      • 2.1.2 Cyazofamid Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Rudong Zhongyi
      • 2.2.1 Business Overview
      • 2.2.2 Cyazofamid Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Rudong Zhongyi Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Cyazofamid Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Cyazofamid Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Cyazofamid Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Cyazofamid Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Cyazofamid Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Cyazofamid Market Analysis by Regions

    • 4.1 Global Cyazofamid Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Cyazofamid Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Cyazofamid Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Cyazofamid Sales and Growth Rate (2014-2019)
    • 4.3 Europe Cyazofamid Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Cyazofamid Sales and Growth Rate (2014-2019)
    • 4.5 South America Cyazofamid Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Cyazofamid Sales and Growth Rate (2014-2019)

    5 North America Cyazofamid by Country

    • 5.1 North America Cyazofamid Sales, Revenue and Market Share by Country
      • 5.1.1 North America Cyazofamid Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Cyazofamid Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Cyazofamid Sales and Growth Rate (2014-2019)
    • 5.3 Canada Cyazofamid Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Cyazofamid Sales and Growth Rate (2014-2019)

    6 Europe Cyazofamid by Country

    • 6.1 Europe Cyazofamid Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Cyazofamid Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Cyazofamid Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Cyazofamid Sales and Growth Rate (2014-2019)
    • 6.3 UK Cyazofamid Sales and Growth Rate (2014-2019)
    • 6.4 France Cyazofamid Sales and Growth Rate (2014-2019)
    • 6.5 Russia Cyazofamid Sales and Growth Rate (2014-2019)
    • 6.6 Italy Cyazofamid Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Cyazofamid by Country

    • 7.1 Asia-Pacific Cyazofamid Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Cyazofamid Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Cyazofamid Revenue and Market Share by Country (2014-2019)
    • 7.2 China Cyazofamid Sales and Growth Rate (2014-2019)
    • 7.3 Japan Cyazofamid Sales and Growth Rate (2014-2019)
    • 7.4 Korea Cyazofamid Sales and Growth Rate (2014-2019)
    • 7.5 India Cyazofamid Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Cyazofamid Sales and Growth Rate (2014-2019)

    8 South America Cyazofamid by Country

    • 8.1 South America Cyazofamid Sales, Revenue and Market Share by Country
      • 8.1.1 South America Cyazofamid Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Cyazofamid Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Cyazofamid Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Cyazofamid Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Cyazofamid Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Cyazofamid by Countries

    • 9.1 Middle East and Africa Cyazofamid Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Cyazofamid Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Cyazofamid Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Cyazofamid Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Cyazofamid Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Cyazofamid Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Cyazofamid Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Cyazofamid Sales and Growth Rate (2014-2019)

    10 Global Cyazofamid Market Segment by Type

    • 10.1 Global Cyazofamid Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Cyazofamid Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Cyazofamid Revenue and Market Share by Type (2014-2019)
    • 10.2 Type I Sales Growth and Price
      • 10.2.1 Global Type I Sales Growth (2014-2019)
      • 10.2.2 Global Type I Price (2014-2019)
    • 10.3 Type II Sales Growth and Price
      • 10.3.1 Global Type II Sales Growth (2014-2019)
      • 10.3.2 Global Type II Price (2014-2019)

    11 Global Cyazofamid Market Segment by Application

    • 11.1 Global Cyazofamid Sales Market Share by Application (2014-2019)
    • 11.2 Downy Mildew Sales Growth (2014-2019)
    • 11.3 Oomycetes Diseases Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Cyazofamid Market Forecast (2019-2024)

    • 12.1 Global Cyazofamid Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Cyazofamid Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Cyazofamid Market Forecast (2019-2024)
      • 12.2.2 Europe Cyazofamid Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Cyazofamid Market Forecast (2019-2024)
      • 12.2.4 South America Cyazofamid Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Cyazofamid Market Forecast (2019-2024)
    • 12.3 Cyazofamid Market Forecast by Type (2019-2024)
      • 12.3.1 Global Cyazofamid Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Cyazofamid Market Share Forecast by Type (2019-2024)
    • 12.4 Cyazofamid Market Forecast by Application (2019-2024)
      • 12.4.1 Global Cyazofamid Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Cyazofamid Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Cyazofamid . Industry analysis & Market Report on Cyazofamid is a syndicated market report, published as Global Cyazofamid Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Cyazofamid market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,780.52
      		4,170.78
      		5,561.04
      		3,246.84
      		4,870.26
      		6,493.68
      		541,314.00
      		811,971.00
      		1,082,628.00
      		289,988.40
      		434,982.60
      		579,976.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo